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ABSTRACT 
Objective Reporting of clinical significance is recommended because findings can be 
statistically significant without being relevant to patients. For aiding clinical interpretation of 
the Tinnitus Questionnaire (TQ), many investigators use a 5-point change cut off as a 
minimal clinically important difference (MCID). But there are shortcomings in how this value 
was originally determined.  
Design The MCID was evaluated by analysing retrospective clinical data on the TQ 
(German-version). Following recommended standards, multiple estimates were computed 
using anchor- and distribution-based statistical methods. These took into account not only 
patients’ experience of clinical improvement, but also measurement reliability.  
Study sample Pre- and post-intervention scores were assessed for 202 patients.  
Results Our six estimates ranged from 5 to 21 points in TQ change score from pre- to post- 
intervention. The 5-point TQ change score was obtained using a method that considered 
change between groups, and did not account for measurement error or bias. The size of the 
measurement error was considerable, and this comprises interpretation of individual patient 
change scores. 
Conclusions To enhance confidence that a TQ change over time in individual patients is 
clinically meaningful, we advise at least the median MCID of 12 points. 
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INTRODUCTION 
There is little evidence-based guidance to facilitate design decisions for definitive trials that 
evaluate treatment efficacy for adults with tinnitus. Eligibility criteria, characteristics of 
enrolled participants, tinnitus-related outcome instruments, and criteria for interpreting any 
observed treatment-related change are all highly diverse across clinical trials and this 
precludes direct comparison across findings (Hall et al., 2016a). With respect to outcome 
instruments, while trial findings report group-level statistical results on the treatment-related 
change they rarely seek to additionally interpret whether or not those observed 
improvements are clinically meaningful. Reporting of clinical significance is recommended 
because findings can be statistically significant, without being clinically significant (i.e. there 
is a change but it is not relevant to patients). A minimal clinically important difference (MCID) 
should be defined as a threshold fo  a change in global questionnaire score over which a 
patient or physician would consider that change to be meaningful and worthwhile. Hence, 
determining MCID is critical for conducting and interpreting meaningful clinical trials, as well 
as for facilitating the establishment of treatment recommendations for patients. If different 
intervention studies interpret their clinical efficacy results in different ways, then findings 
cannot easily be synthesised and conclusions cannot be compared.  
Using a list of 228 clinical trials identified in a recent systematic review (Hall et al., 
2016a), we found that the Tinnitus Handicap Inventory (THI, Newman et al., 1998) was the 
most popular choice of outcome instrument, with the Tinnitus Questionnaire (TQ) second, 
and the Tinnitus Functional Index (TFI, Meikle et al., 2012) third (Hall et al., 2016a). All three 
instruments yield a composite score reflecting the impact of tinnitus. The THI test-retest 
reliability indicates an MCID of 20 points or greater for interpreting individual patients 
(Newman et al., 1998).  TFI development paid careful attention to its responsiveness to 
treatment-related change (more so than the THI or TQ) and the authors estimated an MCID 
of 13 points or greater (Meikle et al., 2012).  
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The TQ was originally developed by Hallam et al. (1988). It was modified and 
translated into German by Hiller and Goebel (1992). In Germany, therefore, the TQ tends to 
be chosen in preference to the THI or TFI (Hall et al., 2016a). This work concerns the 
German version of the TQ (henceforth referred to as TQ). The global TQ score is based on 
the 42 questions corresponding to the TQ subscales, with a maximum score of 84, with 
higher values indicating greater symptom severity. Goebel and Hiller (1998) proposed a four-
category grading system for diagnostic assessment (mild, moderate, severe, very severe), 
but no recommendations about MCID. The review of 228 clinical trials found that 15 of those 
studies reporting the TQ then went on to interpret individual pre-post change scores using a 
threshold criterion for defining ‘clinical improvement’ ((Hall et al., 2016a, see Supplemental 
File 1). Eleven of those studies used a 5-point cut off, with four studies justifying that choice 
by citing an article by Kleinjung et al. (2007, p591). But this article contains insufficient 
information to explain how this threshold was determined, and the original data are no longer 
accessible [Kleinjung, personal communication]. A subsequent report, which reiterated a 5-
point cut off, did not fully account for the test-retest reliability of the measurement (Adamchic 
et al. 2012). 
This Technical Report responds to an appeal by Hall et al. (2016b) to reassess 
clinically important difference estimates taking account of measurement reliability as well as 
the patient experience of clinical improvement (Mokkink et al., 2010; Terwee et al., 2007).  
METHODS 
This was a retrospective analysis using a clinical dataset that comprised 202 patients whom 
received the Heidelberg Neuro-Music-Therapy intervention at the DZM e.V. (German Center 
for Music Therapy Research) in Germany, from 2011 to 2016. This intervention is targeted at 
patients with a clinical diagnosis of chronic tonal tinnitus persisting for a minimum of 6 
months. Median duration was 7 years. Patients were not randomised and were not blinded 
to the treatment. Inclusion criteria were representative for patients receiving this form of 
treatment in routine clinic:  
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• age > 18 
• no severe psychiatric disorders (such as major depression, psychosis, dementia) 
• no ongoing medication interfering with therapy (such as high dosages of 
tranquilizers) or possibly aggravating tinnitus (such as cisplatin) 
• no substance abuse 
• no treatable, ongoing organic causes for tinnitus (apart from hearing loss; ear 
disorders in the past possibly causing tinnitus were okay if patients had recovered 
from the disease) 
• baseline TQ > 30.  
All patients were treated according to the compact model of the Heidelberg Neuro-Music 
Therapy, which was nine sessions of individual music therapy over five consecutive days, 
combined with psychoeducation, relaxation training, tinnitus habituation, and stress 
management (Argstatter et al., 2015). The Heidelberg Model aims to restore emotional well-
being. The TQ is a reasonable choice of outcome measure since it has a large number of 
items assessing emotional well-being associated with tinnitus. The mean age of the sample 
was 52 years (SD 13), with 134 men and 68 women. The TQ was completed both before 
and after therapy. In addition, patients were asked an anchor question about whether their 
tinnitus symptoms were changed by the music therapy. There were pre-defined response 
options (worsened, unaffected or improved) and those whose tinnitus worsened or improved 
were asked a follow-up question about its severity. This enabled us to classify responses 
into five categories: ‘much better’, ‘slightly better’, ‘no change’, ‘slightly worse’ and ‘much 
worse’. We refer to this question as the Clinical Global Impression (CGI) scale. 
MCID analyses 
There is no single method for determining what the MCID should be. But methodologists 
generally recommend triangulating the results of multiple methods for determining clinically 
important difference (Revicki et al., 2006, see also Adamchic et al., 2012). Here we report 
findings from anchor-based and distribution-based methods. First, anchor-based methods 
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assess what change on the TQ corresponds with a minimal important change defined on the 
anchor which is an external criterion used to operationalise a relevant or important 
difference. Typically the anchor is the CGI. A within-patients estimate corresponds to the 
change in global TQ scores for patients who responded ‘slightly better’ and can be a good 
indicator of the smallest change that is important from the individual patients’ perspective to 
identify ‘responders’. A between-patients estimate corresponds to the degree of change in 
global TQ scores between the anchor response categories ‘slightly better’ and ‘no change’ 
and can be a good indicator of the smallest change for determining differences between 
treatment groups.  
Second, distribution-based methods convey information about reliability (i.e. the 
consistency of the TQ measurement in test-retest situations). These were the IntraClass 
Correlation (ICC) used to assess reliability over test-retest situations, and Limits of 
Agreement (LoA) and Smallest Detectable Change (SDC) used to estimate measurement 
error. The sample size fulfils the recommended minimum requirement (> 50 participants) for 
these distribution-based reliability analyses (Terwee et al., 2007). The ICC partials out 
variance across participants from other sources of variance such as measurement error. 
Furthermore, our calculated ICC values were interpreted as follows: <0.40 (poor), 0.40-0.75 
(good) and >0.75 (excellent) (Fleiss, 1986). A two-way mixed model was chosen in which 
patients were random but time points were fixed. The LoA estimates the interval between 
which lies 95% of the difference in scores between ‘pre’ and ‘post’. The assumption is that if 
the mean difference between the scores was zero (i.e. no bias), then 95% of the data points 
would be within ±2 standard deviations of the mean difference. The SDC is related to the 
Standard Error of Measurement (SEM) (SDC=1.96*√2* SEMCon) and it expresses the 
smallest change that would have to occur for that change to be considered a ‘real’ change 
not solely due to measurement error. We used SEMCon, which is less susceptible to 
systematic differences in time points than SEMAgree. We also used the 1/2 standard deviation 
rule since this magnitude of difference between groups corresponds to Cohen d = 0.5 and 
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represents a medium effect size (Cohen, 1988; Norman et al., 2003; Sawilowsky, 2009). 
Finally, we calculated the Reliable Change Index (RCI, i.e. the pre- versus post-intervention 
difference divided by the standard error of the difference), used widely in psychological 
research (Jacobson and Truax, 1991). 
RESULTS 
For 20 patients we did not have data to categorise the 5-point CGI, and so we estimated 
MCID using the remaining n=182. Individual anchor response categories were screened for 
their associated TQ change scores. TQ change was determined by subtracting the global 
score at pre-treatment from the post-treatment baseline (‘post-pre’). Thus, a negative TQ 
change score indicates a tinnitus improvement. The ‘slightly better’ CGI group had a 12.0 
point ‘post-pre’ reduction on the TQ (SD 9.8), and for the ‘no change’ CGI group it was 7.4 
points (SD 10.6) (Table 1). Global TQ change scores plotted as a function of CGI groups, 
revealed the expected positive monotonic function (Figure 1). If the TQ measures the same 
theoretical construct as the CGI, then the two scales should show excellent convergent 
validity. The degree of convergence was assessed by the correlation coefficient, where at 
least 0.30 is acceptable for inclusion in MCID calculations (Andresen, 2000). Spearman’s 
rank correlation was borderline acceptable (r=0.28, p<0.001). However, the 95% confidence 
intervals around each category mean score were very broad (Figure 1, Table 1) such that 
the difference between ‘slightly better’ and ‘no change’ CGI groups for the TQ change was 
not statistically reliable according to post-hoc testing (p=0.12). Revicki et al. (2006) note that 
in cases of variability in the ‘no change’ CGI group, then the MCID may be based on the TQ 
change difference between the ‘no change’ and the ‘slightly better’ CGI groups (i.e. the 
between-patients estimate). This was 4.6 mean score points in our dataset.  
** Tables 1 and 2 ** 
For the distribution-based results, we first assessed reliability using the pre- and 
post-treatment scores for the ‘no change’ CGI-I group (n=52), since these patients should 
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show stable TQ ‘pre’ and ‘post’ scores. Results are given in Table 2. The observed ICC 
value of 0.61 (95% CI 0.41/0.76) indicated that 61% of the variability in the TQ could be 
attributed to the true score. This value was acceptable (Andresen, 2000; Fleiss, 1986) and 
demonstrated the way in which patients differed from one another was reasonably stable at 
retest. Measurement error is the other form of reliability and here this refers to the difference 
between the TQ score and its true value. Terwee et al’s (2007) criteria for acceptable 
confidence in the observed estimates of psychometric reliability are that the LoA is higher 
than the reported SEMCon, and that the SDC and LoA values are broadly equivalent. Values 
obtained for LoA, SEMCon and SDC demonstrate that these criteria were met (see Table 2 
and Figure 1, inset panel). The LoA indicates that a change score of 21 points or smaller 
was likely to be due to measurement error, and that 94% of the data points fell between -
28.54 and +13.70. The 1/2 standard deviation was 6.46, and the RCI was 12.89. 
The clinical relevance of these different MCID criteria was explored by comparing the 
classification of responders and non-responders, according to the CGI, with the classification 
according to each of the above statistical methods. Supplemental File 2 reports these 
findings. No single classification using TQ change scores fully agreed with the patients’ own 
report, indicating the added value of using the CGI. 
Finally we noted a tendency to deviate towards a tinnitus improvement and away 
from the expected value of zero because the ‘no change’ CGI group still scored a mean 
reduction of 7.4 points on the TQ, corresponding to a medium effect size (Cohen d = 0.62, 
Cohen, 1988; Sawilowsky, 2009). This pattern is suggestive of a systematic bias in patient 
reporting. 
DISCUSSION 
We examined the clinically important difference using a range of anchor- and distribution-
based methods for a large retrospective sample of clinical data. From the present data, a 
numerical change in TQ score of 5 points did not reliably identify which patients in routine 
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clinic perceived an improvement in tinnitus-related emotional well-being, and it did not 
reliably distinguish patients reporting an improvement from those reporting no change in 
symptoms. Instead, a pragmatic interpretation of the data would indicate using the most 
central MCID value of 12 points (the median) for interpreting individual patient change 
scores on the TQ. This accounts for the effect of patient reporting bias but may not obviate 
measurement error in the clinical interpretation.  
Cautions about a minimal clinically important difference (MCID) of 5 change points 
Taken in isolation, the anchor-based method suggested an MCID of 4.6 change points on 
the German TQ for interpreting a treatment-related difference in improvement between 
patient groups. This MCID agree with the 5 integer change points reported by others (e.g. 
Kleinjung et al.; 2007; Adamchic et al., 2012). However, three noteworthy observations lead 
us to caution against using a small magnitude MCID when interpreting change in individual 
patients and when interpreting data collected from non-randomised, or unblinded clinical 
studies.  
First, we observed a wide variability across patients, which meant that the 4.6 point 
difference in TQ change scores between the ‘slightly better’ and ‘no change’ CGI groups was 
not statistically significant. Second, we observed that those patients perceiving ‘no change’ 
still reported a mean TQ decrease in 7.4 points on post-treatment assessment compared 
with pre-treatment baseline (Table 1). A potential source of this systematic bias could be an 
ascertainment bias since the data were not collected in the context of a randomised, blinded, 
controlled trial. Each patient was told to expect some effects to occur during the 5 days of 
music therapy, but that they should continue exercises afterwards, and each was aware that 
his/her clinician was reviewing the post-intervention data. Third, when we considered the 
distribution-based estimates, they were all greater than 5 points (Table 2). Previous 
estimates of 5 points in global TQ change score are probably too conservative because they 
have not accounted for measurement error or such bias. 
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Implications for clinical trials and clinical practice 
In conclusion, the findings add to a growing body of evidence that MCID values on these 
multi-attribute questionnaire instruments for tinnitus can be quite large. Based on the 
observed data, at least the median MCID of 12 points.is advised when interpreting TQ 
change scores. For clinical trials, an MCID of 12 points provides an evidence-based 
parameter in the power calculation needed to estimate sample size, it provides an evidence-
based threshold for interpreting clinical significance of treatment-related change in ‘before 
and after’ study designs or of group mean differences in controlled study designs, and it 
provides an evidence-based numerical a priori criterion for classifying ‘responders’ and ‘non-
responders’. For clinical practice, TQ change scores can be informative, but clinicians should 
primarily remain sympathetic towards the patient’s perception of any treatment-related 
change. 
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Figure 1. The main panel presented the global TQ score changes from baseline, 
categorised by the Clinical Global Impression scale. Error bars indicate 95% confidence 
interval around the mean. The inset panel on the right presents a summary of the anchor- 
and distribution-based estimates of the MCID for the TQ. 
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Table 1. TQ characteristics of Clinical Global Impression (CGI) scale categories. CI= Confidence Interval. 
CGI Number of 
patients 
∆TQ,  
Mean (SD) 
95% CI of ∆TQ Cohen d 95% CI of d 
Much better 20 -14.7 (12.6) -27/-2.4 1.28 -3.63/6.71 
Slightly better 92 -12.0 (9.8) -21.7/-2.3 1.09 -0.97/3.52 
No change 52 -7.4 (10.6) -17.7/2.9 0.62 -2.48/4.05 
Slightly worse 12 -7.6 (12.3) -19.7/4.5 0.57 -5.59/9.62 
Much worse 6 2.5 (20.6) -18.1/23.1 -0.17 -8.09/16.72 
Not coded for severity 20     
 
 
Table 2. Reliability evaluation of the TQ for the n=52 participants in the “no change” category of the CGI. Agree=Agreement; CI=Confidence 
Intervals; Con=Consistency; N=size of dataset at each visit; SD=standard deviation; SE=standard error; ICC=Intra Class Correlation; 
LoA=Limits of Agreement; SDC= Smallest Detectable Change; SEM=Standard Error of Measurement. ICC values are reported for the single 
measure which applies to individual scores. CI= Confidence Interval. 
Descriptive statistics Reliability Measurement error 
Mean (SD) Difference Reliability SEM SDC LoA 
Screening Day1 Mean 
diff 
SE SDdiff ICC 
(95% CI) 
Con Agree SDC LoA LoA Lower 
limit 
(95%CI) 
LoA Upper 
limit (95%CI) 
% 
43.60 
(11.36) 
36.17 
(12.59) 
-7.42 1.46 10.56 0.61  
(0.41, 0.76) 
7.47 38.58 20.71 21.12 -28.54        
( -33.58, 
 -23.50) 
13.70  
(8.66,  
18.74) 
94.0 
 
 
Supplemental File 1. Summary of numerical criteria for what constitutes a minimal clinically important difference (MCID) on versions of the TQ 
using investigator-reported data extracted from 228 trials (Hall et al., 2016a). NR = not reported 
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Supplemental File 2. This table illustrates how many patients in our sample meet the different numerical criteria for what constitutes a minimal 
clinically important difference (MCID). Above the bold line are all those numerical criteria reported in the Technical report. Below the line are 
two additional criteria that were used only once in our review of 228 clinical trials (Hall et al., 2016a). 
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Figure 1. The main panel presented the global TQ score changes from baseline, categorised by the Clinical 
Global Impression scale. Error bars indicate 95% confidence interval around the mean. The inset panel on 
the right presents a summary of the anchor- and distribution-based estimates of the MCID for the TQ.  
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Supplemental File 1. Summary of numerical criteria for what constitutes a minimal clinically 
important difference (MCID) on versions of the TQ using investigator-reported data extracted 
from 228 trials (Hall et al., 2016a). NR = not reported 
 
TQ version Investigator-reported MCID Reference Source of the 
MCID value 
 
Criterion of improvement is a global TQ score reduction >5 points 
 
Version of 
translation 
unknown 
Quote: "‘therapeutic success’ (TQ 
reduction >5)"  
Chung et al. 
(2012) 
Kleinjung et al. 
(2007) 
German version Quote: "treatment responders (TQ 
reduction > 5)" 
Langguth (2012a) NR 
German version Quote: "treatment responders (TQ 
reduction > 5)" 
Langguth (2013a) NR 
 
Criterion of improvement is a global TQ score reduction >=5 points 
 
German version Quote: "benefit from treatment, 
which was reflected by a reduction 
of the TQ score of five points or 
more" 
Kleinjung et al. 
(2007) 
Justification 
presented in the 
article 
German version Quote: "treatment response which 
was defined as amelioration of at 
least 5 points in the TQ" 
Kreuzer et al. 
(2011) 
NR 
German version Quote: "treatment response, which 
was defined as amelioration of at 
least 5 points in the TQ" 
Kreuzer et al. 
(2012) 
Kleinjung et al. 
(2008) 
German version Quote: "a clinical relevant change 
of tinnitus severity (i.e. 5 points on 
the (TQ) questionnaire of Goebel 
and Hiller" 
Landgrebe et al. 
(2008) 
Kleinjung et al. 
(2007) 
German version Quote: "treatment responders (TQ 
reduction ≥5)" 
Langguth (2012b) NR 
German version Quote: "treatment responders ?  
total score reduction ≥ 5" 
Langguth (2013b) NR 
German version Quote:"treatment responders, 
defined as a minimum difference of 
five points" 
Langguth et al. 
(2014) 
Kleinjung et al. 
(2007) 
German version Quote: "treatment responders as 
defined by a reduction in the 
Tinnitus Questionnaire score of ≥5 
points" 
Lehner et al. 
(2013) 
Goebel and Hiller 
(1994) 
 
Criterion of improvement is a global TQ score reduction >6.1 points 
 
German version Quote: "a critical difference of 6.1 
points" 
Argstatter et al. 
(2015) 
Goebel and Hiller 
(1998) 
 
Criterion of improvement is a global TQ score reduction >10 points 
 
German version Quote: "clinically relevant tinnitus 
improvement ? patients who 
demonstrated reduction of >10 
Kleinjung et al. 
(2008) 
Kleinjung et al. 
(2007) 
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2 
 
points" 
 
Criterion of improvement is a global TQ score reduction of >= 25% points 
 
Version of 
translation 
unknown 
Quote: "when looking at the 
predefined clinically relevant effect 
of at least 25% improvement (10 
points)" 
Hoekstra et al. 
(2013) 
NR 
 
Criterion of improvement is a global TQ score that crosses the boundary from 47 to 46 points 
 
German version Quote: "Tinnitus is considered to be 
'compensated' at a TQ level of = 46 
(no secondary symptoms) and 
'decompensated' at a TQ level of = 
47 (permanent annoyance and 
psychological strain)" 
Mazurek et al. 
(2009) 
Goebel and Hiller 
(1999) 
 
 
Additional references cited in the Supplemental Table, but not cited in the main body 
of the article: 
Argstatter, H., Grapp, M., Hutter, E., Plinkert, P.K., & Bolay, H.V. (2015). The effectiveness 
of neuro-music therapy according to the Heidelberg model compared to a single 
session of educational counseling as treatment for tinnitus: a controlled trial. J 
Psychosom Res, 78(3), 285-92. 
Chung, H.K., Tsai, C.H., Lin, Y.C., Chen, J.M., Tsou, Y.A., Wang, C.Y., Lin, C.D., Jeng, F.C., 
Chung, J.G., & Tsai, M.H. (2012). Effectiveness of theta-burst repetitive transcranial 
magnetic stimulation for treating chronic tinnitus. Audiol Neurootol, 17(2), 112-20. 
Goebel, G., Hiller, W. (1998). Tinnitus-Fragebogen:(TF); ein Instrument zur Erfassung von 
Belastung und Schweregrad bei Tinnitus; Handanweisung. Hogrefe, Verlag für 
Psychologie. 
Goebel, G., Hiller, W. (1999). Quality management in the therapy of chronic tinnitus. In 
Proceedings of the 6th International Tinnitus Seminar. Hazell JW (ed). London: The 
Tinnitus and Hyperacusis centre. pp 357-63. 
Hoekstra, C. E., Versnel, H., Neggers, S. F., Niesten, M. E., & Van Zanten, G. A. (2013). 
Bilateral low-frequency repetitive transcranial magnetic stimulation of the auditory 
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cortex in tinnitus patients is not effective: a randomised controlled trial. Audiology and 
Neurotology, 18(6), 362-373. 
Kleinjung, T., Eichhammer, P., Landgrebe, M., Sand, P., Hajak, G., Steffens, T., & Langguth, 
B. (2008). Combined temporal and prefrontal transcranial magnetic stimulation for 
tinnitus treatment: a pilot study. Otolaryngology--Head and Neck Surgery, 138(4), 497-
501. 
Kreuzer, P. M., Landgrebe, M., Schecklmann, M., Poeppl, T. B., Vielsmeier, V., Hajak, G., & 
Langguth, B. (2011). Can temporal repetitive transcranial magnetic stimulation be 
enhanced by targeting affective components of tinnitus with frontal rTMS? A 
randomized controlled pilot trial. Frontiers in Systems Neuroscience, 5, 88. 
Kreuzer, P. M., Goetz, M., Holl, M., Schecklmann, M., Landgrebe, M., Staudinger, S., & 
Langguth, B. (2012). Mindfulness-and body-psychotherapy-based group treatment of 
chronic tinnitus: a randomized controlled pilot study. BMC Complementary and 
Alternative Medicine, 12(1), 1. 
Landgrebe, M., Binder, H., Koller, M., Eberl, Y., Kleinjung, T., Eichhammer, P., & Langguth, 
B. (2008). Design of a placebo-controlled, randomized study of the efficacy of 
repetitive transcranial magnetic stimulation for the treatment of chronic tinnitus. BMC 
Psychiatry, 8(1), 1. 
Langguth, B. (2012a). NCT01663311 Repetitive magnetic stimulation with double cone coil 
in chronic tinnitus (Ti-CDC).  
Langguth, B. (2012b). NCT01663324 rTMS for the treatment of chronic tinnitus: optimisation 
by stimulation of the cortical tinnitus network (multisite rTMS).  
Langguth, B. (2013a). NCT01907022 Combined rTMS and relaxation in chronic tinnitus.  
Langguth B. (2013b). NCT01965028 Daily bi-temporal transcranial random noise stimulation 
in tinnitus (tRNS-tin). 
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Langguth, B., Landgrebe, M., Frank, E., Schecklmann, M., Sand, P. G., Vielsmeier, V., & 
Kleinjung, T. (2014). Efficacy of different protocols of transcranial magnetic stimulation 
for the treatment of tinnitus: pooled analysis of two randomized controlled studies. The 
World Journal of Biological Psychiatry, 15(4), 276-285. 
Lehner, A., Schecklmann, M., Kreuzer, P. M., Poeppl, T. B., Rupprecht, R., & Langguth, B. 
(2013). Comparing single-site with multisite rTMS for the treatment of chronic tinnitus–
clinical effects and neuroscientific insights: study protocol for a randomized controlled 
trial. Trials, 14(1), 1. 
Mazurek, B., Haupt, H., Szczepek, A. J., Sandmann, J., Gross, J., Klapp, B. F., & Caffier, P. 
P. (2009). Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled 
pilot study. Journal of Negative Results in Biomedicine, 8(1), 1. 
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Supplemental File 2. This table illustrates how many patients in our sample meet the 
different numerical criteria for what constitutes a minimal clinically important difference 
(MCID). Above the bold line are all those numerical criteria reported in the Technical report. 
Below the line are two additional criteria that were used only once in our review of 228 
clinical trials (Hall et al., 2016a). 
Responders are categorised as individuals whose change pre- versus post-treatment 
change score either meets or exceeds the MCID defined by that statistical method. Non-
responders are those individuals whose change pre- versus post-treatment change score is 
less than the MCID defined by that statistical method. The three Clinical Global Impression 
(CGI) categories (better, unchanged, worse) form the benchmark for comparing each 
statistical method with the patients’ subjective personal impression. Three further statistical 
metrics assist interpretation of these data.  
Cohen’s kappa coefficient measures the degree of agreement between the responder 
classification based on CGI and that based on the statistical method. Kappa coefficients for 
some of the methods fell between 0.2 and 0.4 indicated no better than ‘fair’ agreement 
(Landis and Koch, 1977). Kappa coefficients for LoA and the boundary method indicated 
poor agreement.  
Sensitivity refers to the percent of responders (classification based on CGI) that were 
correctly diagnosed by the statistical method, while specificity refers to the percent of non-
responders (classification based on CGI) that were correctly diagnosed by the statistical 
method.  
Taken in combination and over the whole group, the SEMCon method showed the highest 
value of kappa and the best trade-off between sensitivity and specificity. However, the 
important caveat to this interpretation is that the CGI may not be the ‘true’ classification of 
treatment-related improvement because self-reports can be prone to bias. 
 
Method of estimating individual 
responders 
Responders Non-
responders 
Kappa Sensitivity 
% 
Specificity 
% 
‡ CGI 115 85  
LoA & SDC 32 170 0.08 20.0 89.4 
slightly better & RCI  90 112 0.19 53.0 67.1 
SEMCon 124 78 0.30 73.9 55.3 
½ SD 132 70 0.22 74.8 47.1 
slightly better – no change 138 64 0.20 76.5 42.4 
* boundary for compensated vs 
decompensated 
46 156 0.03 24.3 78.8 
percent improvement (at least 
25%) 
99 103 0.27 60.9 67.1 
 
‡ CGI data available for 200 participants 
* In the German version of the TQ, a total score of 47 and above (range = 0-84 points) has been 
regarded as a clinically significant level of distress (Goebel and Hiller, 1998; Hallam, 2008). 


Additional references cited in the Supplemental Table, but not cited in the main body 
of the article: 
Hallam, R.S. (2008). Manual of the Tinnitus Questionnaire (TQ). Revised and updated. 
London: Polpresa Press. 
Landis, J.R. Koch, G.G. (1977). The measurement of observer agreement for categorical 
data". Biometrics, 33 (1): 159–174.  
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